Ruth Owusu

Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial

Kwaku Poku Asante, Salim Abdulla, Sélidji Todagbé Agnandji et al. · The Lancet Infectious Diseases · 2011 · 136 citations

Veterinary Medicine, Immunology, Infectious Diseases +11

Randomized Controlled Trial of RTS,S/AS02D and RTS,S/AS01E Malaria Candidate Vaccines Given According to Different Schedules in Ghanaian Children

Seth Owusu‐Agyei, Daniel Ansong, Kwaku Poku Asante et al. · PLoS ONE · 2009 · 88 citations · Full text

Veterinary Medicine, Child Health, Infectious Diseases +17

Evaluation of the Safety and Immunogenicity of the RTS,S/AS01_EMalaria Candidate Vaccine When Integrated in the Expanded Program of Immunization

Sélidji Todagbé Agnandji, Kwaku Poku Asante, John Lyimo et al. · The Journal of Infectious Diseases · 2010 · 76 citations

Veterinary Medicine, Infectious Diseases, Pediatrics +17

T Cell Responses to the RTS,S/AS01E and RTS,S/AS02D Malaria Candidate Vaccines Administered According to Different Schedules to Ghanaian Children

Daniel Ansong, Kwaku Poku Asante, Johan Vekemans et al. · PLoS ONE · 2011 · 66 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

An Open Label, Randomised Trial of Artesunate+Amodiaquine, Artesunate+Chlorproguanil-Dapsone and Artemether-Lumefantrine for the Treatment of Uncomplicated Malaria

Seth Owusu‐Agyei, Ruth Owusu, Martin Adjuik et al. · PLoS ONE · 2008 · 53 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16